Entelos Inc.



                                  ENTELOS, INC.

   NOTICE OF PRELIMINARY RESULTS FOR THE TWELVE MONTHS ENDED 31 DECEMBER 2007

                               Date: 16 April 2008

Entelos, Inc. (LSE: ENTL), a leading life sciences company building predictive
computer models and "virtual patients" for drug discovery and development,
announces that it will be releasing its preliminary results for the twelve
months ended 31 December 2007 on Wednesday 16 April 2008.

Analyst Briefing:

An Analyst briefing will be held at 10:00 am on 16 April at the offices of
Buchanan Communications, 45 Moorfields, London, EC2.

For further information please contact:

Entelos, Inc.
Jill Fujisaki, Vice President, Investor                    Tel: +1-650-572-5400
 Relations
Buchanan Communications
Lisa Baderoon / Mary-Jane Johnson                        Tel +44-0-20-7466-5000

About Entelos

Entelos, Inc. (www.entelos.com) is a US-based life sciences company applying
next-generation predictive technologies to revolutionize the way medicines are
discovered, developed, and utilized. The Company leverages its proprietary in
silico disease models, "virtual patients", and toxicology reference systems to
develop safer and more effective drugs and support pharmaceutical R&D and
commercialization. In addition to internal drug programs in rheumatoid arthritis
and women's health, Entelos provides customized technology and research services
to global pharmaceutical and health-care companies in cardiovascular diseases,
asthma, obesity, diabetes, hematopoeisis (anemia), cholesterol metabolism, and
skin sensitization. The company is also developing a model in oncology and is
collaborating with the FDA to build a model of drug-induced liver injury.
Entelos offers cost-effective drug development capabilities through its
strategic alliance with India-based Jubilant Biosys.
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Entelos Regs Charts.
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Entelos Regs Charts.